Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cann Group ( (AU:CAN) ) has shared an update.
Cann Group shareholders have approved all seven resolutions put to an extraordinary general meeting, providing board and management with a mandate to proceed with a series of capital-related and incentive measures. Investors backed the election of non‑executive director Mike Ryan and endorsed multiple option issues linked to a recent placement and share purchase plan, shortfall commitments, and lead manager arrangements, as well as attaching options for CEO and managing director Jennifer Pilcher and director Ryan. The meeting also ratified the prior issue of SPP shortfall shares, collectively strengthening the company’s capital structure and aligning key executives and advisers with shareholder interests as Cann Group continues to fund its growth strategy in the medicinal cannabis market.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited is an Australian-listed company operating in the medicinal cannabis sector. It focuses on cultivating, manufacturing and supplying cannabis and cannabis-derived products for medical and related markets, aligning with growing domestic and international demand for regulated cannabinoid-based therapies.
Average Trading Volume: 5,190,075
Technical Sentiment Signal: Sell
Current Market Cap: A$14M
See more insights into CAN stock on TipRanks’ Stock Analysis page.